ASTELLAS PHARMA, INC. (ALPMY)
Clinical trial NCT07455812 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-07-16 3. primary completion date: 2026-07-31 → 2026-07-16
Clinical trial NCT07455812 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-07-16 3. primary completion date: 2026-07-31 → 2026-07-16
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical